Recent research has shown that increased STUB1 expression can facilitate cancer immune evasion and lead to resistance against immunotherapy.[43, 44] Given that the role of METTL5, the third highest‐ranking gene, in antitumor immunity remains largely unexplored, we selected it for further studies (Figure 2A). The gene discussed is STUB1; the disease is cancer.